These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20371703)

  • 41. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages.
    Matsunawa M; Amano Y; Endo K; Uno S; Sakaki T; Yamada S; Makishima M
    Toxicol Sci; 2009 May; 109(1):50-8. PubMed ID: 19244278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
    Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D
    Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of LXRalpha signaling by vitamin D receptor: possible role of VDR in bile acid synthesis.
    Jiang W; Miyamoto T; Kakizawa T; Nishio SI; Oiwa A; Takeda T; Suzuki S; Hashizume K
    Biochem Biophys Res Commun; 2006 Dec; 351(1):176-84. PubMed ID: 17054913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction.
    Dwivedi PP; Omdahl JL; Kola I; Hume DA; May BK
    J Biol Chem; 2000 Jan; 275(1):47-55. PubMed ID: 10617584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific.
    Narayanan R; Sepulveda VA; Falzon M; Weigel NL
    J Biol Chem; 2004 Nov; 279(45):47298-310. PubMed ID: 15331595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver.
    Rodríguez-Ortigosa CM; Celay J; Olivas I; Juanarena N; Arcelus S; Uriarte I; Marín JJ; Avila MA; Medina JF; Prieto J
    Gastroenterology; 2014 Nov; 147(5):1084-93. PubMed ID: 25066374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1.
    Dwivedi PP; Muscat GE; Bailey PJ; Omdahl JL; May BK
    J Mol Endocrinol; 1998 Jun; 20(3):327-35. PubMed ID: 9687155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
    Martorell S; Hueso L; Gonzalez-Navarro H; Collado A; Sanz MJ; Piqueras L
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1587-97. PubMed ID: 27283745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3).
    Chen J; Doroudi M; Cheung J; Grozier AL; Schwartz Z; Boyan BD
    Cell Signal; 2013 Dec; 25(12):2362-73. PubMed ID: 23896121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Examination of VDR/RXR/DRIP205 Interaction, Intranuclear Localization, and DNA Binding in Ras-Transformed Keratinocytes and Its Implication for Designing Optimal Vitamin D Therapy in Cancer.
    Jusu S; Presley JF; Williams C; Das SK; Jean-Claude B; Kremer R
    Endocrinology; 2018 Mar; 159(3):1303-1327. PubMed ID: 29300860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of ligand-dependent vitamin D receptor transactivation by the cardiotonic steroid bufalin.
    Nakano H; Matsunawa M; Yasui A; Adachi R; Kawana K; Shimomura I; Makishima M
    Biochem Pharmacol; 2005 Nov; 70(10):1479-86. PubMed ID: 16183038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of chromatin organization of vitamin D target genes.
    Carlberg C; Dunlop TW
    Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells.
    Li T; Jahan A; Chiang JY
    Hepatology; 2006 Jun; 43(6):1202-10. PubMed ID: 16729332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
    Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
    PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
    Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B
    Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
    Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cells.
    Munetsuna E; Nakabayashi S; Kawanami R; Yasuda K; Ohta M; Arai MA; Kittaka A; Chen TC; Kamakura M; Ikushiro S; Sakaki T
    J Mol Endocrinol; 2011 Oct; 47(2):209-18. PubMed ID: 21693624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3).
    Buitrago C; Vazquez G; De Boland AR; Boland R
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1150-6. PubMed ID: 11741312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (23S)- and (23R)-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1alpha,25-dihydroxyvitamin D(3).
    Ishizuka S; Miura D; Ozono K; Saito M; Eguchi H; Chokki M; Norman AW
    Steroids; 2001; 66(3-5):227-37. PubMed ID: 11179730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.